HPV infection and p53 and p16 expression in esophageal cancer: are they prognostic factors?

Table 4 Risk of cancer progression or death according to HPV, p53 and p16 status

Model	Variable of interest^a	Progression-free survival		Specific-cancer survival
Model	Variable of interest^a	HR	[CI^95%]	HR	[CI^95%]
1	HPV	1.042	[0.293: 3.709]	1.901	[0.926: 3.900]
2	p16	1.137	[0.383: 3.378]	1.268	[0.617: 2.604]
3	p53	1.318	[0.646: 2.689]	1.177	[0.726: 1.907]

^aModel adjusted by sex. Clinical stage and treatment (surgery and chemoradiotherapy). HR: Hazard ratio

ISSN: 1750-9378